Dalvie, Deepak
Crinetics Pharmaceuticals, Inc.,
United States
2024 Rank: 157152
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1492 out of 148458 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157152 | 173986 |
| Total Cites | 4530 | 4971 |
| H-index | 36 | 37 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 58 | 58 |
| Number of Single+First Authored Papers | 25 | 25 |
| Total Cites to Single+First Authored Papers | 1136 | 1230 |
| Number of Single+First+Last Authored Papers | 40 | 40 |
| Total Cites to Single+First+Last Authored Papers | 1620 | 1750 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3815 | 4045 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.23 |
| Self-Citation Percentage |
8.87%
|
|
Dalvie, Deepak
Crinetics Pharmaceuticals, Inc.,
United States
2023 Rank: 157665
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1541 out of 140593 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 157665 | 171634 |
| Total Cites | 4251 | 4670 |
| H-index | 34 | 36 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 52 | 52 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 1068 | 1159 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 1514 | 1636 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3585 | 3808 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.23 |
| Self-Citation Percentage |
8.97%
|
|
Dalvie, Deepak
Bristol-Myers Squibb,
United States
2022 Rank: 154980
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1523 out of 134745 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 154980 | 168006 |
| Total Cites | 3900 | 4299 |
| H-index | 32 | 35 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 48 | 48 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 993 | 1082 |
| Number of Single+First+Last Authored Papers | 38 | 38 |
| Total Cites to Single+First+Last Authored Papers | 1389 | 1507 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3288 | 3503 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.23 |
| Self-Citation Percentage |
9.28%
|
|
Dalvie, Deepak
Bristol-Myers Squibb,
United States
2021 Rank: 152406
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1522 out of 131063 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 152406 | 164836 |
| Total Cites | 3769 | 4157 |
| H-index | 31 | 34 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 47 | 47 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 959 | 1046 |
| Number of Single+First+Last Authored Papers | 37 | 37 |
| Total Cites to Single+First+Last Authored Papers | 1337 | 1452 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3186 | 3398 |
| Ratio of Total Citations to Distinct Citing Papers | 1.18 | 1.22 |
| Self-Citation Percentage |
9.33%
|
|
Dalvie, Deepak
Celgene Corporation,
United States
2020 Rank: 151760
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Pharmacology & Pharmacy
SubField 2:
Medicinal & Biomolecular Chemistry
Rank in SubField 1: 1446 out of 94611 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 151760 | 166334 |
| Total Cites | 3291 | 3663 |
| H-index | 31 | 32 |
| Hm-index | 11 | 12 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 45 | 45 |
| Number of Single+First Authored Papers | 23 | 23 |
| Total Cites to Single+First Authored Papers | 859 | 944 |
| Number of Single+First+Last Authored Papers | 36 | 36 |
| Total Cites to Single+First+Last Authored Papers | 1174 | 1286 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 2777 | 2985 |
| Ratio of Total Citations to Distinct Citing Papers | 1.19 | 1.23 |
| Self-Citation Percentage |
10.16%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.